GGrantIndex
Sort

40,608 grants matching prostate cancer

Exploring Statin Pleiotropic Effects within a Very Large EHR Cohort

$406,123
Wei-Qi Wei · Vanderbilt University Medical Center · R01 · FY2017 · HL

Tumor-specific autoantibodies for SCLC early detection

$406,116
A. McGarry Houghton · Fred Hutchinson Cancer Center · R01 · FY2024 · CA

Signaling Network Dynamics in Metastatic Prostate Cancer

$405,894
David S. Lawrence · Univ Of North Carolina Chapel Hill · R01 · FY2009 · CA

Administrative Core

$405,884
Arul M Chinnaiyan · University Of Michigan At Ann Arbor · U2C · FY2024 · CA

Signaling importance of ‘functionless’ lyso-PAF, an inactive form of platelet activating factor, in melanoma with mutant Nras

$405,834
Jing Chen · University Of Chicago · R01 · FY2023 · CA

Prostate Specific Anti-androgen Therapy for Localized Prostate Cancer

$405,681
Maithili Rairkar · Alessa Therapeutics, Inc. · R43 · FY2023 · CA

Immune-inflammatory signaling and hormone-refractory prostate cancer evolution.

$405,676
Jun-Li Luo · Scripps Research Institute, The · R01 · FY2012 · CA

Immune-inflammatory signaling and hormone-refractory prostate cancer evolution.

$405,676
Jun-Li Luo · Scripps Research Institute, The · R01 · FY2015 · CA

CDK inhibitors in tumor progression

$405,656
Andrew Koff · Sloan-Kettering Inst Can Research · R01 · FY2008 · CA

8P22 ALTERATIONS, IN PROSTATE, BREAST AND ESOPHAGEAL CA

$405,649
Thomas Jefferson University · R01 · FY2001 · CA

Academic-Industry Partnership for the Translation of a 4D in vivo Dosimetry Approach for Radiation Therapy

$405,629
Liangzhong Shawn Xiang · University Of California-Irvine · R37 · FY2024 · CA

Activation of androgen biosynthesis and drug metabolism by cytochrome b5

$405,600
Richard J Auchus · University Of Michigan At Ann Arbor · R01 · FY2025 · GM

Whole Genome Scan for Pancreatic Cancer Risk in the Pancreatic Cancer CohortCons

$405,572
Rachael Stolzenberg-Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA

Targeting KDM4B, a novel alternative splicing regulator, in castration-resistant prostate cancer (CRPC)

$405,500
Zhi-Ping Liu · Ut Southwestern Medical Center · R01 · FY2022 · CA

High Throughput Screening for SCAP Inhibitors as Pancreas Cancer Therapeutics

$405,491
Peter John Espenshade · Johns Hopkins University · R01 · FY2022 · CA

Effects of Arsenic on Human Prostate Stem Cells and Prostate Cancer Risk

$405,450
Gail S Prins · University Of Illinois At Chicago · R01 · FY2016 · ES

Transgenic Animal Models for Prostate Cancer

$405,422
Robert J Matusik · Vanderbilt University · R01 · FY2012 · CA

Atlases to Report and Correlate Radiotherapy Dose Distributions with Outcomes

$405,304
Andrew Jackson · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA

Development Of Drugs Acting At Adenosine Receptors

$405,261
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK

PRECISE MRI DIRECTED SONIC ABLATION OF PROSTATE CANCER

$405,172
Stanford University · R33 · FY2002 · CA

Role of immune cell OGR1 in prostate cancer development and the mechanisms involv

$405,077
Yan Xu · Indiana University Indianapolis · R01 · FY2015 · CA

Prolonged cadmium exposure promotes oxidative stress-dependent transcription and breast cancer progression

$405,075
Maggie C Louie · Dominican University · R15 · FY2016 · ES

Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL)

$405,053
Jim Hu · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA

Radiation Force Imaging of Prostate Cancer and Guidance of Biopsy Procedures

$405,051
Kathryn R Nightingale · Duke University · R01 · FY2010 · CA

3D Prostate Histochemometry to Predict Disease Recurrence

$405,047
Rohit Bhargava · University Of Illinois At Urbana-Champaign · R01 · FY2016 · CA